Trials / Completed
CompletedNCT02956993
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
A Phase 1, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Vonapanitase Administered Following Angioplasty of a Distal Popliteal, Tibial or Peroneal Artery in Patients With Peripheral Artery Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Proteon Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vonapanitase | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
- First posted
- 2016-11-07
- Last updated
- 2019-05-02
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02956993. Inclusion in this directory is not an endorsement.